Phase 2 Type 2 Diabetes Trial Rosenstock et al., The Lancet (2023) Rosenstock and colleagues conducted a phase 2, randomized, double-blind, double-dummy, placebo-controlled and active-comparator-controlled, parallel-group trial of retatrutide in adults with type 2 diabetes
Greenhaff, J
Thats why its worth tracking progress beyond the scalethink measurements, energy, strength, or how your clothes fit
Les effets secondaires possibles peuvent inclure des crampes abdominales, des ballonnements, des difficults respiratoires et des ractions allergiques
In these trials, participants were randomized to receive a GLP-1 receptor agonist intervention at various doses and placebo plus usual care or standard care only as control groups